4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-23-000517
Chief Commercial Officer sold 13,325 shares at an average $12.55 ($167,195)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rabinowitz Michael Chief Commercial Officer | 2023-01-03 | Sale | −1,425 | $13.01 | $18,544 | 138,043 | D |
| Rabinowitz Michael Chief Commercial Officer | 2023-01-03 | Sale | −11,900 | $12.49 | $148,651 | 126,143 | D |
| Open-market sales · 13,325 sh · avg $12.55 · $167,195 | |||||||
Loading xslF345X03/doc4.xml…